Skip to main content
68°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVO
Recent news which mentions NVO
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia Drug
October 18, 2024
Tickers
NEWS
NVO
TSVT
Tags
Equities
Market News
NVO
From
Benzinga
Behind the Scenes of Novo Nordisk's Latest Options Trends
October 17, 2024
Tickers
NVO
Tags
Options
Markets
NVO
From
Benzinga
Novo Nordisk's Weight Loss Drug Ozempic Associated With Reduced Opioid, Alcohol Use Disorder Incidences, Study Shows
October 17, 2024
Tickers
NEWS
NVO
Tags
Health Care
News
Large Cap
From
Benzinga
'Miracle' Weight Loss Drug Ozempic And Similar Drugs Reduce Alcohol And Opioid Overdose, Study Reveals
October 17, 2024
Tickers
NEWS
NVO
SBC
Tags
Benzinga
General
addiction
From
Benzinga
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years
October 16, 2024
Tickers
NEWS
NVO
Tags
Benzinga
News
Trading Ideas
From
Benzinga
Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?
October 16, 2024
Tickers
LLY
NVO
Tags
LLY
Recent Press Releases
Market News
From
Motley Fool
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
October 15, 2024
Tickers
CTLT
HAL
LLY
NEWS
Tags
Stories That Matter
CTLT
RIO
From
Benzinga
Hims & Hers Health Stock Is Popping Monday: What's Behind The Move?
October 14, 2024
Tickers
HIMS
LLY
NEWS
NVO
Tags
HIMS
NVO
Movers
From
Benzinga
3 No-Brainer Growth Stocks to Buy in October
October 13, 2024
Tickers
LLY
NVO
VRTX
Tags
NVO
Market News
VRTX
From
Motley Fool
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
October 11, 2024
Tickers
ALT
AMGN
LLY
NEWS
Tags
Benzinga
VKTX
Biotech
From
Benzinga
Criminal Networks Cash In On Demand For Weight Loss Drugs, Authorities Say
October 11, 2024
Tickers
LLY
NEWS
NVO
Tags
Stories That Matter
AI Generated
Biotech
From
Benzinga
Analyst Ratings For Novo Nordisk
October 10, 2024
Tickers
NVO
Tags
Benzinga
BZI/AAR
NVO
From
Benzinga
FTC Faces Pressure to Block Novo Nordisk-Catalent Merger Over Antitrust Fears
October 10, 2024
Tickers
CTLT
LLY
NEWS
NVO
Tags
Benzinga
General
CTLT
From
Benzinga
Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves
October 10, 2024
Tickers
LLY
NEWS
NVO
Tags
Stories That Matter
Biotech
General
From
Benzinga
2 No-Brainer Dividend Growth Stocks to Buy Right Now
October 10, 2024
Tickers
LLY
NVO
Tags
NVO
Market News
Recent Press Releases
From
Motley Fool
A Closer Look at Novo Nordisk's Options Market Dynamics
October 09, 2024
Tickers
NVO
Tags
Market News
Markets
Options
From
Benzinga
Got $5,000? These 3 Growth Stocks Are on Sale Right Now.
October 09, 2024
Tickers
CELH
DELL
NVO
Tags
NVO
Market News
CELH
From
Motley Fool
What's Going With WeightWatchers Stock On Wednesday?
October 09, 2024
Tickers
LLY
NEWS
NVO
WW
Tags
Benzinga
Top Stories
General
From
Benzinga
Prediction: 3 of Wall Street's Most Influential Stocks Can Plunge if Kamala Harris Wins in November
October 08, 2024
Tickers
AAPL
META
NVO
Tags
NVO
Market News
AAPL
From
Motley Fool
Billion-Dollar News for Eli Lilly Stock Investors
October 07, 2024
Tickers
GS
LLY
NVO
Tags
Market News
GS
NVO
From
Motley Fool
Regeneron Chief Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says Company Targets Muscle Preservation For Its Obesity Drugs
October 07, 2024
Tickers
LLY
NEWS
NVO
REGN
Tags
General
Benzinga
Media
From
Benzinga
Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?
October 06, 2024
Tickers
LLY
NEWS
NVO
RHHBY
Tags
News
LLY
Health Care
From
Benzinga
Prediction: These 2 Stocks Will Join Nvidia, Meta, Apple, Amazon, and Microsoft in the Trillion-Dollar Club by 2030
October 06, 2024
Tickers
NVO
V
Tags
V
Recent Press Releases
NVO
From
Motley Fool
Novo Nordisk's Options: A Look at What the Big Money is Thinking
October 04, 2024
Tickers
NVO
Tags
Market News
NVO
Markets
From
Benzinga
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
October 04, 2024
Tickers
HIMS
LLY
NEWS
NVO
Tags
General
Analyst Ratings
Top Stories
From
Benzinga
England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access
October 04, 2024
Tickers
LLY
NEWS
NVO
Tags
General
Top Stories
Benzinga
From
Benzinga
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
October 04, 2024
Tickers
AZN
MRK
NEWS
NVO
Tags
SNY
Large Cap
News
From
Benzinga
Popular Weight Loss Drugs Like Ozempic Show Gap Between Clinical Trial Promises And Real-World Use, Study Reveals
October 03, 2024
Tickers
LLY
NEWS
NVO
Tags
Large Cap
News
LLY
From
Benzinga
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
October 03, 2024
Tickers
ABBV
GSK
NEWS
NVO
Tags
ABBV
drug prices
Government
From
Benzinga
Hims & Hers Health Stock Is Tumbling Thursday: Here's Why
October 03, 2024
Tickers
HIMS
LLY
NEWS
NVO
Tags
HIMS
Market News
Movers
From
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.